Ocular Biodistribution Study for Topically Applied ESBA105
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ESBA105, a single-chain (scFv) antibody
against TNF-alpha, efficiently penetrates into the anterior chamber and the vitreous body
upon topical administration to the eye.